|4Mar 9, 2:34 PM ET

Keyes Jeffry R. 4

4 · CNS Pharmaceuticals, Inc. · Filed Mar 9, 2022

Insider Transaction Report

Form 4
Period: 2022-03-07
Transactions
  • Award

    Common Stock

    2022-03-07$0.30/sh+11,100$3,29411,100 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $0.2685 to $2999. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    ownership.xmlPrimary